Loading insider details...
Beta
Latest Form 4 (Sep 18, 2026): Sale of 1,610 CBIO shares, $28.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 18, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Sale | 1,610 | $28.8K |
| Jun 23, 2026 | CRESCENT BIOPHARMA, INC. (CBIO) | Sale | 42,305 | $761.1K |
| Dec 17, 2025 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 45,117 | n/a |
| Dec 10, 2025 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/Award | 345,672 | n/a |
| Mar 13, 2024 | Dyne Therapeutics, Inc. (DYN) | Exercise/Conversion | 153,931 | $852.8K |
| Mar 12, 2024 | Dyne Therapeutics, Inc. (DYN) | Sale | 9,086 | $234.9K |
| Mar 2, 2024 | Dyne Therapeutics, Inc. (DYN) | Exercise/Conversion | 5,520 | $30.6K |
| Jan 31, 2024 | Dyne Therapeutics, Inc. (DYN) | Gift | 20,000 | n/a |
| Jan 5, 2024 | Dyne Therapeutics, Inc. (DYN) | Exercise/Conversion | 51,183 | $52.7K |
| Dec 12, 2023 | Dyne Therapeutics, Inc. (DYN) | Sale | 7,585 | $81.3K |